COST EFFECTIVENESS EVALUATION OF APIXABAN, DABIGATRAN RIVAROXABAN AND WARFARIN FOR PREVENTION OF TROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION IN TRINIDAD AND TOBAGO

被引：0
|
作者：
Garita, M. [1 ]
Peralta, M. [1 ]
Dookie, T. A. [2 ]
机构：
[1] Pfizer Cent Amer & Caribbean, San Jose, Costa Rica
[2] Westshore Med Ctr, Port Of Spain, Trinidad Tobago
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.678
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV84
引用
收藏
页码：A116 / A117
页数：2
相关论文
共 50 条
  • [41] DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION
    Noseworthy, Peter
    Yao, Xiaoxi
    Sangaralingham, Lindsey R.
    Abraham, Neena
    McBane, Robert
    Gersh, Bernard
    Shah, Nilay
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 692 - 692
  • [42] Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    [J]. THROMBOSIS RESEARCH, 2020, 185 : 135 - 141
  • [43] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [44] An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
    Mantha, Simon
    Ansell, Jack
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 108 (03) : 476 - 484
  • [45] Dabigatran but not rivaroxaban or apixaban reduces fibrinolytic resistance in patients with atrial fibrillation
    Ammollo, C. T.
    Semeraro, F.
    Incampo, F.
    Dellanoce, C.
    Paoletti, O.
    Testa, S.
    Colucci, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 118 - 118
  • [46] PHARMACOECONOMIC ANALYSIS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON WITH RIVAROXABAN OR APIXABAN
    Gay-Molina, J. G.
    Herran, S.
    Sorensen, S.
    Gonschior, A. K.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [47] Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
    Athanasakis, Kostas
    Boubouchairopoulou, Nadia
    Karampli, Eleftheria
    Tarantilis, Filippos
    Savvari, Paraskevi
    Bilitou, Aikaterini
    Kyriopoulos, John
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (02) : 123 - 133
  • [48] Direct Comparisons of Apixaban, Dabigatran and Rivaroxaban in Atrial Fibrillation
    Jansson, Martin U.
    Sjogren, Vilhelm
    Sjalander, Sara
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    [J]. CIRCULATION, 2018, 138
  • [49] Cost-effectiveness of apixaban vs warfarin for secondary stroke prevention in atrial fibrillation
    Kamel, Hooman
    Easton, J. Donald
    Johnston, S. Claiborne
    Kim, Anthony S.
    [J]. NEUROLOGY, 2012, 79 (14) : 1428 - 1434
  • [50] Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective
    Kostas Athanasakis
    Nadia Boubouchairopoulou
    Eleftheria Karampli
    Filippos Tarantilis
    Paraskevi Savvari
    Aikaterini Bilitou
    John Kyriopoulos
    [J]. American Journal of Cardiovascular Drugs, 2017, 17 : 123 - 133
12345